A Game Changer Against Covid: New Vaccine from Novovax
Yesterday, the Financial Times reported that Novavax, a US-based pharmaceutical firm, had developed a type of vaccine against Covid using ...
Read moreDetailsYesterday, the Financial Times reported that Novavax, a US-based pharmaceutical firm, had developed a type of vaccine against Covid using ...
Read moreDetailsIt was nearly two years ago, in December 2019 that COVID-19 first appeared. We went through a global equivalent of ...
Read moreDetails
Impakter keeps you informed through its ESG news platform and empowers your business through the Impakter Index.
To assess and improve your company’s ESG performance, explore Klimado’s ESG dashboard and assessment tools at www.klimado.com.
Registered Office Address
Klimado GmbH
Niddastrasse 63,
60329, Frankfurt am Main, Germany
IMPAKTER is a Klimado GmbH website
Impakter is a publication that is identified by the following International Standard Serial Number (ISSN) is the following 2515-9569 (Printed) and 2515-9577 (online – Website).
Office Hours - Monday to Friday
9.30am - 5.00pm CEST
stories [at] impakter.com
© 2026 IMPAKTER. All rights reserved.